Copy For Citation
Karaca M., Tural D., Akar E., Unal D., Bayraktaoglu M., AKYÜREK N., ...More
JOURNAL OF BUON, vol.25, no.1, pp.268-273, 2020 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
25
Issue:
1
-
Publication Date:
2020
-
Journal Name:
JOURNAL OF BUON
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
-
Page Numbers:
pp.268-273
-
Keywords:
lung cancer, NSCLC, immunotherapy, PD-1, PD-L1, DEATH-LIGAND 1, PROGNOSTIC-FACTOR, PULMONARY ADENOCARCINOMA, CLINICAL-SIGNIFICANCE, PROTEIN EXPRESSION, DOCETAXEL, STATISTICS, MUTATIONS, NIVOLUMAB
-
Gazi University Affiliated:
Yes
Abstract
Purpose: There are conflicting results in the literature about the relationship between PD-1/PD-L1 expression and prognosis in non-small cell lung cancer (NSCLC). The purpose of this study was to identify the relationship between NSCLC patients' clinicopathologic characteristics and PD-1/PD-L1 expression.